ARHGDIB Antibody (monoclonal) (M01)
Mouse monoclonal antibody raised against a full length recombinant ARHGDIB.
|Calculated MW||22988 Da|
|Other Names||Rho GDP-dissociation inhibitor 2, Rho GDI 2, Ly-GDI, Rho-GDI beta, ARHGDIB, GDIA2, GDID4, RAP1GN1|
|Target/Specificity||ARHGDIB (AAH09200, 1 a.a. ~ 201 a.a) full-length recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.|
|Format||Clear, colorless solution in phosphate buffered saline, pH 7.2 .|
|Storage||Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.|
|Precautions||ARHGDIB Antibody (monoclonal) (M01) is for research use only and not for use in diagnostic or therapeutic procedures.|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
LyGDI is a promising biomarker for ovarian cancer. Zhen H, et al. Int J Gynecol Cancer, 2010 Apr. PMID 20375790.Pathways of metastasis suppression in bladder cancer. Said N, et al. Cancer Metastasis Rev, 2009 Dec. PMID 20013033.Genetic susceptibility to distinct bladder cancer subphenotypes. Guey LT, et al. Eur Urol, 2010 Feb. PMID 19692168.PTEN identified as important risk factor of chronic obstructive pulmonary disease. Hosgood HD 3rd, et al. Respir Med, 2009 Dec. PMID 19625176.Consensus transcriptome signature of perineural invasion in pancreatic carcinoma. Abiatari I, et al. Mol Cancer Ther, 2009 Jun. PMID 19509238.
If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at firstname.lastname@example.org.